The Top Causes of Vaginal Itching and Swelling: When to Seek Help

Vaginal itching and swelling (often involving the vulva and external genital tissues) are common concerns that prompt many people to seek medical advice. These symptoms can range from mild and transient to severe and persistent, and they may indicate a variety of conditions — infectious, inflammatory, dermatologic, hormonal, or mechanical. Accurate diagnosis is essential to guide effective treatment and to prevent complications.

This article reviews the major causes of vaginal itching and swelling, describes how clinicians evaluate these symptoms, outlines treatment strategies for the most common diagnoses, and explains when to seek medical care. Information is based on clinical guidance and patient resources from leading medical organizations (ACOG, NIH/NLM, Mayo Clinic, Cleveland Clinic).

Sources:

American College of Obstetricians and Gynecologists (ACOG): https://www.acog.org
National Institutes of Health / MedlinePlus: https://medlineplus.gov
Mayo Clinic: https://www.mayoclinic.org
Cleveland Clinic: https://my.clevelandclinic.org

Understanding the anatomy and terminology

Before discussing causes, it helps to be precise:

Vulva: the external genital structures (labia majora, labia minora, clitoral area, vestibule, and opening of the urethra and vagina).
Vagina: the internal muscular canal extending from the vulvar vestibule to the cervix.
Vaginitis: inflammation of the vaginal mucosa, commonly associated with discharge, odor, pain, or itching.
Vulvitis: inflammation of the vulva; may occur with or without vaginitis.

Itching and swelling may involve the vulva, the vagina, or both. Because the vulvar skin is thin and sensitive, it is particularly prone to irritation from infections, allergens, and dermatologic conditions.

Identifying the common causes of vaginal itching and swelling

The following conditions account for the majority of cases of vulvovaginal itching and swelling seen in clinical practice.

Vulvovaginal candidiasis (yeast infection)

Cause: Overgrowth of Candida species, most often Candida albicans, within the vagina and vulva.
Typical symptoms: Intense vulvar itching or burning, vulvar swelling or redness, thick white “curd-like” vaginal discharge, discomfort with wiping or intercourse.
Risk factors: Recent antibiotic use, pregnancy, uncontrolled diabetes, immunosuppression, hormonal changes, and certain contraceptives.
Notes: Vulvovaginal candidiasis is a very common condition; many people experience at least one episode during their lives. Recurrent vulvovaginal candidiasis (defined as four or more episodes per year) warrants further evaluation.

Clinical resources: Mayo Clinic patient information on vaginal yeast infection (https://www.mayoclinic.org/diseases-conditions/vaginal-yeast-infection) and ACOG practice information.

Bacterial vaginosis (BV)

Cause: Disruption of the normal lactobacillus-dominant vaginal flora with overgrowth of anaerobic bacteria such as Gardnerella vaginalis and others.
Typical symptoms: Thin, gray-white discharge with a characteristic “fishy” odor (often noticed after intercourse), mild irritation or itching, and sometimes vulvar swelling if inflammation extends externally.
Risk factors: New or multiple sexual partners, douching, intrauterine devices (some studies), and smoking.
Notes: BV is the most common cause of symptomatic vaginal discharge in women of reproductive age and is associated with obstetrical complications (e.g., preterm delivery) and an increased risk of acquiring sexually transmitted infections (STIs).

Clinical resources: CDC and NIH/MedlinePlus pages on bacterial vaginosis; Mayo Clinic overview (https://medlineplus.gov/ency/article/000898.htm).

Trichomoniasis

Cause: Infection with the protozoan parasite Trichomonas vaginalis.
Typical symptoms: Vaginal or vulvar itching, frothy yellow-green discharge, vulvar redness and swelling, and discomfort with urination or intercourse. Some individuals are asymptomatic.
Transmission: Sexually transmitted; sexual partners should be treated simultaneously to prevent reinfection.
Treatment: Oral nitroimidazole therapy (metronidazole or tinidazole) is effective.

Clinical resources: CDC and Mayo Clinic pages on trichomoniasis (https://www.mayoclinic.org/diseases-conditions/trichomoniasis).

Genital herpes (HSV infection)

Cause: Herpes simplex virus type 1 or 2 infecting the genital mucosa and skin.
Typical presentation: Initial infection may produce clusters of painful blisters or ulcers on the vulva or around the vaginal opening, accompanied by swelling, itching, burning, and sometimes systemic symptoms (fever, malaise). Recurrent episodes tend to be milder.
Notes: Herpes can present with itching and swelling before lesions become obvious. Diagnosis is by viral culture, PCR, or clinical assessment; antiviral therapy can shorten outbreaks and decrease severity.

Clinical resources: CDC and Mayo Clinic pages on genital herpes (https://www.mayoclinic.org/diseases-conditions/genital-herpes).

Sexually transmitted infections (chlamydia, gonorrhea)

Cause: Bacterial sexually transmitted pathogens such as Chlamydia trachomatis and Neisseria gonorrhoeae infecting the lower genital tract.
Typical symptoms: These infections can cause vaginal discharge and pelvic pain; they less commonly cause pronounced external vulvar itching or swelling alone but can contribute to vaginitis, cervicitis, and ascending infection (pelvic inflammatory disease) if untreated.
Notes: Nucleic acid amplification tests (NAATs) on vaginal or cervical swabs are the diagnostic standard. Prompt treatment prevents complications.

Clinical resources: CDC STI pages; NIH/MedlinePlus.

Contact dermatitis and allergic reactions (irritant or allergic vulvitis)

Cause: Direct irritation or allergy of the vulvar skin from soaps, detergents, fabric softeners, douches, spermicides, lubricants, latex condoms, topical products, fragrance, or hygiene products.
Typical symptoms: Intense itching, burning, redness, swelling, and sometimes blistering or dry, scaly skin. Symptoms often localize to areas of contact and may worsen after product use.
Notes: Avoidance of the offending agent is the mainstay of treatment; topical emollients and, when indicated, topical corticosteroids or antihistamines may relieve symptoms.

Clinical resources: Cleveland Clinic overview of causes of vaginal itching and irritation (https://my.clevelandclinic.org/health/diseases/8432-vaginitis).

Vulvar dermatoses (lichen sclerosus, lichen planus, psoriasis)

Lichen sclerosus: A chronic inflammatory skin disorder often affecting the vulva in postmenopausal individuals but at any age; causes severe itching, white atrophic patches, architectural changes (scarring, narrowing), and discomfort. Requires medical treatment to reduce symptoms and risk of scarring.
Lichen planus: Can affect mucous membranes and skin, resulting in erosive lesions, burning, and irritation of the vulva and vagina; can also lead to scarring and sexual dysfunction if untreated.
Psoriasis and eczema: Chronic inflammatory skin diseases that may involve the vulva; typically cause well-demarcated plaques, scaling, and itching.
Notes: These conditions often require dermatologic or gynecologic evaluation and may need long-term topical therapies (e.g., potent topical corticosteroids) and monitoring.

Clinical resources: ACOG patient information on vulvar skin disorders; NIH resources.

Atrophic vaginitis (genitourinary syndrome of menopause)

Cause: Declining estrogen levels during perimenopause and menopause lead to thinning and drying of the vaginal epithelium and surrounding tissues.
Typical symptoms: Vaginal dryness, itching, burning, thinning of tissues with easy irritation, and swelling or redness from inflammation; dyspareunia and urinary symptoms may coexist.
Treatment: Local estrogen therapy (creams, rings, tablets) is effective for symptomatic relief when appropriate. Nonhormonal moisturizers and lubricants can also help.
Notes: ACOG and other societies provide guidance on management of genitourinary syndrome of menopause.

Clinical resources: ACOG practice bulletins; Mayo Clinic overview of vaginal atrophy (https://www.mayoclinic.org/diseases-conditions/vaginal-atrophy).

Foreign body (retained tampon, contraceptive device, or other object)

Cause: A retained foreign object can provoke chronic local inflammation, infection, odor, discharge, and vulvar or vaginal irritation with swelling.
Typical presentation: Foul-smelling discharge, persistent irritation or swelling, and sometimes spotting. History of recent tampon use or device insertion may be reported.
Management: Removal of the foreign body and treatment of any secondary infection.

Clinical resources: MedlinePlus information on retained tampon complications.

Other less common infectious or inflammatory causes

Condyloma (HPV-related warts), molluscum contagiosum, pelvic dermatologic infections, and autoimmune conditions can all present with vulvar lesions, itching, or swelling. Hidradenitis suppurativa involving the groin/groin folds can cause nodules, scarring, and swelling.
Systemic diseases (e.g., diabetes) increase susceptibility to recurrent infections and severe symptoms.

Clinical evaluation: how providers approach vaginal itching and swelling

Accurate diagnosis relies on a careful history and targeted examination.

Medical history

Key components include:

Onset, duration, and severity of symptoms (itching, burning, pain, swelling).
Description of any vaginal discharge (color, odor, consistency).
Associated symptoms (dysuria, bleeding, systemic symptoms).
Recent antibiotic use, new hygiene products, laundry detergents, or topical agents.
Sexual history, including new or multiple partners, and protection practices.
Pregnancy, menopausal status, diabetes, immunosuppression, or other medical conditions.
Prior similar episodes and previous diagnoses/treatments; response to past therapies.

Physical examination

External inspection of the vulva for erythema, swelling, excoriations, lesions, scars, or suspicious growths.
Speculum examination to assess the vaginal mucosa and cervix, and to collect specimens.
Bimanual pelvic examination if pelvic pain is reported.

Diagnostic testing

Depending on the findings, clinicians may perform:

Vaginal pH testing: Normal vaginal pH is typically ≤4.5; an elevated pH suggests BV or trichomoniasis.
Wet mount microscopy (saline and KOH preparations): Can identify motile trichomonads, clue cells (BV), and budding yeast or pseudohyphae (candida).
Amine (whiff) test: A KOH-induced fishy odor supports BV.
NAAT (nucleic acid amplification tests): Highly sensitive testing for chlamydia, gonorrhea, and trichomonas using vaginal swabs or urine.
HSV PCR or viral culture from lesions when herpes is suspected.
Fungal culture or species identification in recurrent or refractory candidiasis.
Biopsy: When a dermatosis (lichen sclerosus, lichen planus) or suspicious lesion is suspected, a skin biopsy may be necessary.
Blood glucose testing: Considered in recurrent candidiasis or in patients with risk factors for diabetes.

Guidance: Clinicians tailor testing to the clinical presentation and available resources. Empiric treatment without testing is sometimes used for classic presentations (e.g., straightforward yeast infection) but testing is preferred in atypical or recurrent cases.

Treatment strategies by diagnosis

Treatment is cause-specific. Below are standard approaches and important considerations.

Vulvovaginal candidiasis

First-line therapy: Topical azole antifungals (clotrimazole, miconazole) as single or multi-day intravaginal preparations, or a single oral dose of fluconazole 150 mg for uncomplicated cases.
Recurrent disease: For recurrent vulvovaginal candidiasis, an induction regimen followed by suppressive oral therapy (e.g., fluconazole weekly for 6 months) may be prescribed; specialist referral is appropriate.
Special populations: During pregnancy, topical azole therapy is preferred; oral fluconazole is generally avoided for routine use in pregnancy unless benefits outweigh risks.
Address predisposing factors (optimize glycemic control, review antibiotic use, evaluate for immunosuppression).

Sources: ACOG, Mayo Clinic.

Bacterial vaginosis

First-line therapy: Oral metronidazole 500 mg twice daily for 7 days or topical metronidazole gel; oral tinidazole is an alternative. Clindamycin cream is an option but may weaken latex condoms and diaphragms.
Partner treatment: Not routinely recommended for male partners; counsel about sexual practices and recurrence.
Pregnancy: BV treatment is recommended in symptomatic pregnant patients; timely obstetric management is important due to potential pregnancy risks.
Recurrent BV: Relapse is common; repeat or alternative regimens and maintenance strategies may be considered.

Sources: CDC, NIH, Mayo Clinic.

Trichomoniasis

Treatment: Oral metronidazole or tinidazole regimens (single-dose or multi-day), with treatment of sexual partners to prevent reinfection.
Counseling: Abstain from sexual contact until treatment is complete and symptoms resolve.
Note: Metronidazole is contraindicated with alcohol use due to interaction; discuss pregnancy considerations with clinician.

Sources: CDC, Mayo Clinic.

Genital herpes

Antiviral therapy: Oral acyclovir, valacyclovir, or famciclovir can reduce viral shedding, hasten lesion healing, and reduce symptom severity. Episodic or suppressive therapy may be offered depending on frequency of recurrences.
Symptomatic care: Pain control and sitz baths can provide relief.
Counseling: Discuss transmission risk, testing, and potential pregnancy-related implications.

Sources: ACOG, Mayo Clinic.

Contact dermatitis / irritant vulvitis

Avoidance of irritants: Discontinue suspected products (soaps, detergents, perfumes, scented pads).
Skin care: Gentle cleansing with water or mild, fragrance-free cleansers; use cotton underwear; avoid tight clothing.
Topical therapy: Short-course topical corticosteroids can reduce inflammation for allergic or irritant dermatitis under clinician supervision. Emollients and barrier creams soothe irritated skin.
Antihistamines: Oral antihistamines may relieve severe itch.

Clinical guidance: Cleveland Clinic and ACOG patient resources.

Vulvar dermatoses (lichen sclerosus, lichen planus, psoriasis)

Lichen sclerosus: High-potency topical corticosteroids (e.g., clobetasol propionate) are the standard of care to control inflammation and prevent scarring. Long-term follow-up is required because of potential for recurrence and rare risk of malignant transformation.
Lichen planus: Topical or systemic corticosteroids and immunomodulatory agents may be used; management often requires dermatology or vulvar specialty input.
Psoriasis/eczema: Topical treatments tailored to the condition; avoid irritants and maintain skin hydration.

Referral: Dermatology or vulvar clinic referral is warranted for diagnostic confirmation and long-term management.

Sources: ACOG; vulvar dermatology literature.

Atrophic vaginitis (genitourinary syndrome of menopause)

Local estrogen therapy: Vaginal estrogen creams, tablets, or rings can restore mucosal integrity and relieve itching, burning, and dryness.
Nonhormonal options: Vaginal moisturizers and lubricants for symptomatic relief.
Systemic therapy: Consider systemic hormone therapy when appropriate for broader menopausal symptoms; individualized discussion of risks and benefits is necessary.

Resources: ACOG and Mayo Clinic guidance on genitourinary syndrome of menopause.

Foreign body

Removal: Prompt removal of the retained object by a clinician.
Treatment of secondary infection: Antibiotics may be indicated if infection is present.

Prevention and self-care measures

Many episodes of vulvovaginal itching and swelling can be reduced by simple preventive measures:

Avoid douching: Douching disrupts normal vaginal flora and increases risk of BV and other problems (ACOG advises against douching).
Use gentle, fragrance-free hygiene products: Choose mild, pH-neutral cleansers and avoid scented pads, tampons, or wipes.
Wear breathable clothing: Cotton underwear and loose-fitting garments reduce moisture and friction.
Avoid prolonged moisture: Change out of wet swimwear or sweaty exercise clothing promptly.
Practice safer sexual behaviors: Use barrier protection and discuss STI screening with partners.
Manage chronic health conditions: Control blood glucose in diabetes and review medications that predispose to infections.
Consider timing and appropriateness of antibiotics: Use antibiotics only when medically indicated and follow medical guidance for use.

Sources: ACOG, CDC, Mayo Clinic.

When to seek medical care — urgent signs and red flags

Seek prompt medical attention if you experience:

Severe swelling that impairs walking, urination, or hygiene.
High fever, chills, or signs of systemic infection.
New, severe pain localized to the pelvic area.
Suspected sexually transmitted infection (especially if you have new sexual partners).
Recurrent episodes (four or more yeast infections per year) or recurrent BV.
Symptoms during pregnancy (prompt evaluation is important).
Open sores or ulcers, rapidly spreading redness, or large blisters.
Foul-smelling discharge accompanied by fever or abdominal pain.

Early assessment reduces the risk of complications and ensures appropriate therapy.

Complications and long-term consequences

When left untreated or recurrent, vulvovaginal conditions can lead to:

Increased susceptibility to STIs, including HIV (associated with BV and other inflammatory conditions).
Pelvic inflammatory disease from untreated chlamydia or gonorrhea, with potential for infertility.
Obstetrical complications such as preterm labor associated with BV.
Scarring and architectural changes in vulvar dermatoses (lichen sclerosus, lichen planus) that can cause functional impairment.
Psychological distress and impact on quality of life and sexual well-being.

Timely diagnosis and management reduce these risks.

Recurrent or persistent symptoms: special considerations

Recurrent or persistent vulvovaginal itching and swelling require a systematic approach:

Confirm the diagnosis: Re-evaluate with appropriate testing; empiric treatment without confirmation may miss the underlying cause.
Look for predisposing factors: Screen for diabetes, immunodeficiency, and review medications and behavioral contributors.
Consider specialist referral: Dermatology, vulvar clinic, or gynecology referral is recommended for complex vulvar dermatoses, recurrent infections, or unclear diagnoses.
Evaluate for mixed or overlapping conditions: More than one diagnosis (e.g., BV plus candidiasis, or contact dermatitis superimposed on atrophic changes) may be present and require combined management.

Sources: Clinical practice guidance from ACOG and specialty literature.

Special populations

Pregnancy

Many causes of itching and swelling require specific consideration in pregnancy. For example, topical azoles for yeast are generally preferred over systemic oral azole therapy in pregnancy. BV treatment during pregnancy is sometimes recommended because of associated obstetric risks.
Always consult an obstetric provider before initiating therapy during pregnancy.

Sources: ACOG and NIH guidance.

Adolescents

Adolescent patients may have similar causes but require age-appropriate counseling and confidential care for sexually transmitted infections when indicated.

Postmenopausal individuals

Atrophic changes are common with menopause and often respond well to local estrogen therapy. Persistent or unusual lesions warrant evaluation for dermatoses or neoplastic processes.

Practical advice for symptom relief at home

While awaiting medical care or as adjunctive measures:

Use cool compresses or sitz baths to reduce swelling and discomfort.
Apply bland emollients (petrolatum or zinc oxide) to protect irritated skin.
Avoid scratching; keep nails trimmed and consider gloves at night if itching disrupts sleep.
Choose loose, breathable clothing and avoid tight undergarments.
Avoid overuse of topical OTC antifungal or steroid creams without medical guidance; inappropriate use may worsen symptoms or mask other conditions.

How clinicians confirm the diagnosis: sample algorithm

A practical diagnostic approach used by many clinicians:

History and external exam: assess redness, swelling, lesions, and discharge.
Vaginal pH and wet mount: pH >4.5 suggests BV or trichomonas; microscopy can identify clue cells, trichomonads, or yeast.
NAAT testing: routine for suspected chlamydia, gonorrhea, and trichomonas in symptomatic patients.
Empiric therapy: may be offered in classic presentations (e.g., single uncomplicated yeast infection), but testing is recommended for atypical or recurrent cases.
Biopsy or specialist referral: if dermatoses or neoplastic lesions are suspected.

Clinical judgment determines the exact sequence of tests and treatments.

Summary and takeaways

Vaginal and vulvar itching and swelling are common and arise from a broad set of conditions including infections (yeast, BV, trichomonas, herpes), allergic or irritant dermatitis, dermatologic disorders (lichen sclerosus, lichen planus), hormonal atrophy, and foreign bodies.
Accurate history, focused physical exam, and targeted testing (pH testing, microscopy, NAATs, biopsy when indicated) are essential for diagnosis.
Treatment is cause-specific: antifungals for candidiasis, metronidazole or clindamycin for BV, antivirals for herpes, and topical corticosteroids or other immunomodulatory treatments for vulvar dermatoses.
Preventive measures (avoid douching, use gentle products, breathable clothing, safe sexual practices) reduce the risk of recurrent problems.
Seek medical attention for severe, persistent, recurrent, or pregnancy-associated symptoms, or if you notice systemic signs such as fever.

For authoritative, patient-oriented guidance, consult resources from:

American College of Obstetricians and Gynecologists (ACOG): https://www.acog.org
National Institutes of Health / MedlinePlus: https://medlineplus.gov
Mayo Clinic: https://www.mayoclinic.org
Cleveland Clinic: https://my.clevelandclinic.org

If you are experiencing new, severe, or worsening vulvar or vaginal symptoms, contact your primary care provider, gynecologist, or local urgent care to arrange prompt evaluation.